Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Cancer Prevention Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
NCI Clinical and Translational Exploratory/Developmental Studies PAR-25-139 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 10/07/2025 Marjorie Perloff, M.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed) R00, K99 Clinical Trial Not Allowed 10/15/2026 Asad Umar, D.V.M., Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-287 (K99/R00 - Independent Clinical Trial Required) R00, K99 Clinical Trial Required 10/15/2026 Asad Umar, D.V.M., Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-288 (K99/R00 - Independent Basic Experimental Studies with Humans Required) R00, K99 10/15/2026 Asad Umar, D.V.M., Ph.D.
Cancer Prevention and Control Clinical Trials Grant Program PAR-25-167 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/07/2027 Goli Samimi, Ph.D., M.P.H.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-25-070 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 01/07/2027 Edward Sauter, M.D., Ph.D.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis PAR-25-081 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/07/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-25-069 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/07/2027 Edward Sauter, M.D., Ph.D.
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research PAR-24-153 (K12 Clinical Trial Optional) K12 Clinical Trial Optional 02/19/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Enhancing Mechanistic Research on Precision Probiotic Therapies PAR-25-211 (R61/R33 Clinical Trial Optional) R61, R33 Clinical Trial Optional 06/02/2027 Gabriela Riscuta, M.D., CNS